NOV 17, 202623 MINS READ
Isopropyl Palmitate exhibits a linear aliphatic ester structure with the molecular formula C₁₉H₃₈O₂ and a molecular weight of approximately 298.5 g/mol 3. The compound is synthesized through esterification of palmitic acid (hexadecanoic acid) with isopropyl alcohol, typically catalyzed by acid catalysts under controlled temperature conditions 3. This reaction yields a clear, colorless to pale yellow liquid with characteristic physicochemical properties that determine its functional performance across applications.
Key physicochemical parameters critical for distributor quality specifications include:
The ester functional group (–COO–) provides moderate polarity, enabling Isopropyl Palmitate to function as an effective solubilizer for lipophilic active pharmaceutical ingredients (APIs) and cosmetic actives 2,6. The branched isopropyl moiety reduces crystallinity compared to linear esters, enhancing fluidity and skin penetration characteristics 1. Distributors must provide Certificate of Analysis (CoA) documentation verifying these parameters to ensure batch-to-batch consistency for formulation development.
Commercial Isopropyl Palmitate is predominantly manufactured through direct esterification of palmitic acid with isopropyl alcohol in the presence of acid catalysts (typically sulfuric acid or p-toluenesulfonic acid) at temperatures ranging from 80–120°C 3. The reaction equilibrium is driven toward ester formation by continuous removal of water via azeotropic distillation. Alternative synthesis routes include transesterification of palm oil-derived triglycerides with isopropyl alcohol using alkaline or enzymatic catalysts, offering advantages in sustainability and reduced by-product formation.
Industrial-scale production typically involves:
Distributors sourcing from reputable manufacturers should verify Good Manufacturing Practice (GMP) compliance and request process validation documentation. The divided-wall column distillation technology described in recent patents enables enhanced separation efficiency, producing ultra-pure grades (>99.5%) suitable for pharmaceutical applications 10.
Distributors must implement rigorous quality control protocols aligned with pharmacopeial standards (USP, EP, JP) and industry specifications (INCI, CTFA). Critical quality parameters include:
Advanced distributors provide comprehensive analytical packages including ¹H-NMR and ¹³C-NMR spectra for structural confirmation, differential scanning calorimetry (DSC) for thermal characterization, and accelerated stability data (40°C/75% RH for 6 months) demonstrating shelf
| Org | Application Scenarios | Product/Project | Technical Outcomes |
|---|---|---|---|
| BEIERSDORF AG | Cosmetic and dermatological emulsion preparations requiring precise rheological control, including moisturizers, lotions, and topical skincare products. | Eucerin Emulsion Products | Isopropyl palmitate enables viscosity regulation in emulsion formulations without requiring additional thickeners or consistency enhancers, simplifying formulation design and reducing ingredient complexity. |
| Tioga Research Inc. | Pharmaceutical topical formulations for dermatological conditions requiring enhanced drug penetration, including corticosteroid delivery systems and lipophilic API formulations. | Topical Drug Delivery Systems | Formulations containing 5-12 wt% isopropyl palmitate demonstrate enhanced transdermal penetration and solubilization of lipophilic active pharmaceutical ingredients, improving bioavailability of topical therapeutics. |
| Henkel AG & Co. KGaA | Antiperspirant and deodorant products requiring silicone-free formulations with enhanced sensory properties and fragrance performance for personal care applications. | Antiperspirant Formulations | Combination of isopropyl palmitate (4-9 wt%) with ethylhexyl palmitate and C9-C12 alkanes eliminates need for cyclic silicone oils while maintaining superior skin feel and improved fragrance adhesion compared to silicone-based formulations. |
| Eyecro LLC | Ophthalmic pharmaceutical formulations requiring enhanced solubilization and ocular bioavailability of lipophilic active ingredients for treating retinal and posterior segment eye diseases. | Ophthalmic Microemulsion Platform | Isopropyl palmitate serves as oil phase component in oil-in-water microemulsions (2.1-5.5 wt% oil content) enabling topical ocular delivery of lipophilic drugs including fenofibrate for posterior segment eye disease treatment. |
| Sulzer Management AG | Industrial-scale purification of fatty acid isopropyl esters for pharmaceutical-grade applications requiring stringent purity specifications and enhanced process efficiency. | Divided-Wall Column Distillation Technology | Advanced divided-wall column distillation process achieves ultra-high purity (>99.5%) isopropyl palmitate production through efficient separation of fatty acid esters, overhead, bottom, and side streams in single integrated unit. |